PREV PreveCeutical Medical Inc.

CNQ · CA · Healthcare · Biotechnology · preveceutical.com

0.0200CAD+33.33%Mkt Cap: 9.30M $P/E: —3d ago

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development of preventi…

Industry Peers

Biotechnology

Screen all

VRTX

Vertex Pharmaceuticals Incorporated - Common Stock

$127.85BUSDP/E 29.4

MRNA

Moderna, Inc. - Common Stock

$75.86BUSD

REGN

Regeneron Pharmaceuticals, Inc. - Common Stock

$75.69BUSDP/E 18.2

ARGX

argenx SE - American Depositary Shares

Revolution Medicines, Inc. - Common Stock

BeOne Medicines Ltd. - American Depositary Shares

$40.51BUSDP/E 63.9

RPRX

Royalty Pharma plc - Class A Ordinary Shares

$33.03BUSDP/E 30.7

ALNY

Alnylam Pharmaceuticals, Inc. - Common Stock

$29.40BUSDP/E 38.3

ROIV

Roivant Sciences Ltd. - Common Shares

$25.80BUSD

BNTX

BioNTech SE - American Depositary Shares

$24.34BUSD

INSM

Insmed Incorporated - Common Stock

$24.27BUSD

INCY

Incyte Corporation - Common Stock

Genmab A/S - American Depositary Shares

$21.69BUSDP/E 27.4

JAZZ

Jazz Pharmaceuticals plc - Ordinary Shares

$15.30BUSDP/E 16.1

ASND

Ascendis Pharma A/S - Ordinary Share

$14.99BUSDP/E 17.8

EXEL

Exelixis, Inc. - Common Stock

$14.47BUSDP/E 18.4

SMMT

Summit Therapeutics Inc. - Common Stock

$13.37BUSD

Key Statistics

Company

Market Cap9.30M USD

Enterprise Value12.79M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-1.23M USD

Revenue/Share—

Last Price0.0200 CAD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryCA

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-8.13

EV/Revenue—

P/S—

P/B-1.82

EPS (TTM)0.00

EPS (Forward)—

52W Range

0.015011% of range0.0600

52W High0.0600 CAD

52W Low0.0150 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE27.08%

ROA-116.73%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.25M USD

CapEx (TTM)2.16K USD

FCF Margin—

FCF Yield-20.26%

Net Debt3.50M USD

Net Debt/EBITDA-2.22

Balance Sheet

Debt/Equity-0.75

Current Ratio0.16

Quick Ratio0.01

Book Value/Sh-0.01 CAD

Cash/Share0.00 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split5:1

Split DateMay 23, 2018

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.638.19M

Float490.19M

Insiders14.29%

Institutions0.00%

Short Interest

Short Ratio0.6d

Short % Out.0.01%

Shares Short82.00K

Short (prev mo.)1.17K

Technical

SMA 500.0191 (+4.7%)

SMA 2000.0194 (+3.2%)

Beta0.24

S&P 52W Chg14.58%

Avg Vol (30d)197.62K

Avg Vol (10d)181.56K

Technical Indicators

RSI (14)53.4

MACD0.0007

MACD Signal0.0008

MACD Hist.-0.0002

BB Upper0.0251 CAD

BB Middle0.0185 CAD

BB Lower0.0119 CAD

BB Width71.02%

ATR (14)0.0017 CAD

Vol Ratio (20d)0.22x